HCID Member | Biotech Specialty Pharma

EZRA Innovations

4301 W. Markham St. #831
Little Rock, AR 72205-7199 USA
Click for website

Research Sector Biotech Specialty Pharma

Summary Description A Bioscience/Pharmaceutical research and development company specializing in controlled-release drug delivery.

Management CEO-Michael Geranen

Click here for Financial Data
Keywords: generic, drugs, pharmaceutical, alternative, generic drugs


Updated: Apr. 21, 2011


A Bioscience/Pharmaceutical research and development company. EZRA Innovations currently holds exclusive worldwide rights in a controlled-release drug delivery system.......view more

Products / Services

Drug Surfactant Complex (DSC) Deoxycholate is used in combination with active pharmaceutical ingredients (API), DSC possesses the ability to change the chemical moiety of existing drugs and better e......view more

Technology / Differentiation

Although controlled release drug delivery systems do exist, they are unable to control the rate of drug delivery, length of release time, and target area of drug delivery following administration. ...view more

Market / Customers

Generic companies are expected to grow rapidly in the future, as patents for major brand products expire. The role of the generic companies in the pharmaceutical industry of the future is being re-eva......view more

Competitors / Substitutes / Alternatives

Major pharmaceutical companies, niche oriented companies. i.e. Biovail,...view more

Revenue / Funding

Company Seeks: Venture Capital Institutional Investor Awareness M&A Advisors Strategic / Corporate Partners...view more


Phase I EZRA Innovations will generate revenues on a per dose basis from licensing fees and royalties paid by pharmaceutical companies utilizing EZRA Innovation's patented technologies. Phase II ...view more